Determinants of Generic Drug Use Among Medicare Beneficiaries: Predictive Modelling Analysis Using Artificial Intelligence

The U.S. healthcare system has been considering a variety of strategies to encourage the development and use of generic drugs over brand-name drugs, specifically under the Medicare program.